FEDAISF
Federation of Italian Associations of Pharmaceutical Representatives
egr. Dr. Matteo Renzi
President of the Council of Ministers
Palazzo Chigi
Rome
Rome, February 28, 2014
The intervention of dr. Hausermann worried about the pharmaceutical expenditure incurred by the Italian people is at least suspicious.
If the dr. Hausermann did not hold the prestigious office of president of Assogenerici we could accept his reflections aloud, like the fervor of an important man rightly concerned with the community, in difficult times for everyone.
His office, however, and what he represents cannot make him credible and disinterested.
Dr. Hausermann always seems very far from a principle which, in our country is a basic and irreplaceable cornerstone of a consolidated democracy and that is that the individual has the faculty and freedom to choose, in a broad sense, his own economic destiny.
Especially when, within the concept, the right to health is at stake.
And he certainly doesn't like that someone, not expressly authorized, even if authoritative, has to do the math in his pocket.
For a long time, a media campaign has been mounted aimed at giving two fundamental explanations to the Italians:
1) Generic drugs are the same as the original drugs.
2) Generic drugs allow savings for the State, the Regions, the Local Health Authorities.
Some regions have entered into agreements, with doctors, aimed at pro-generic savings, with adherence to a form of objectives, which - if achieved - could have given benefits to everyone. It is to be hoped that - these advantages - do not also include cash prizes for doctors and managers of the Local Health Authorities.
Because if that were the case, the vaunted savings would have taken on the consistency of a round game.
We are convinced that the new Prime Minister, through his institutional offices, also wants to hear the opinion of scientific informants, the only ones to have feedback from the territory of great potential and in absolutely real times.
Both with thousands of visits to doctors every day, and with listening to thousands of patients in every country in Italy, and with the answers from the pharmacies visited on time.
President Renzi, for once, even before listening to Farmindustria and Assogenerici, the Commissions should also hear our opinion.
A precise law, for years, has imposed that scientific reps should not depend on the Marketing and Sales Departments and pharmaceutical companies punctually disregard the laws of the State.
Perhaps the need is emerging to report violations of the law to the public prosecutors, where existing and repeated, to restore the sense of law and dignity
Fabio Carinci
National President Fedaiisf
